key: cord-0888869-v9hawr51 authors: Ebrahimi, Saba; Nonacs, Peter title: Genetic diversity through social heterosis can increase virulence in RNA viral infections and cancer progression date: 2021-05-05 journal: Royal Society open science DOI: 10.1098/rsos.202219 sha: b4629599461710aaa750bad807150f0a6884936d doc_id: 888869 cord_uid: v9hawr51 In viral infections and cancer tumours, negative health outcomes often correlate with increasing genetic diversity. Possible evolutionary processes for such relationships include mutant lineages escaping host control or diversity, per se, creating too many immune system targets. Another possibility is social heterosis where mutations and replicative errors create clonal lineages varying in intrinsic capability for successful dispersal; improved environmental buffering; resource extraction or effective defence against immune systems. Rather than these capabilities existing in one genome, social heterosis proposes complementary synergies occur across lineages in close proximity. Diverse groups overcome host defences as interacting ‘social genomes’ with group genetic tool kits exceeding limited individual plasticity. To assess the possibility of social heterosis in viral infections and cancer progression, we conducted extensive literature searches for examples consistent with general and specific predictions from the social heterosis hypothesis. Numerous studies found supportive patterns in cancers across multiple tissues and in several families of RNA viruses. In viruses, social heterosis mechanisms probably result from long coevolutionary histories of competition between pathogen and host. Conversely, in cancers, social heterosis is a by-product of recent mutations. Investigating how social genomes arise and function in viral quasi-species swarms and cancer tumours may lead to new therapeutic approaches. In viral infections and cancer tumours, negative health outcomes often correlate with increasing genetic diversity. Possible evolutionary processes for such relationships include mutant lineages escaping host control or diversity, per se, creating too many immune system targets. Another possibility is social heterosis where mutations and replicative errors create clonal lineages varying in intrinsic capability for successful dispersal; improved environmental buffering; resource extraction or effective defence against immune systems. Rather than these capabilities existing in one genome, social heterosis proposes complementary synergies occur across lineages in close proximity. Diverse groups overcome host defences as interacting 'social genomes' with group genetic tool kits exceeding limited individual plasticity. To assess the possibility of social heterosis in viral infections and cancer progression, we conducted extensive literature searches for examples consistent with general and specific predictions from the social heterosis hypothesis. Numerous studies found supportive patterns in cancers across multiple tissues and in several families of RNA viruses. In viruses, social heterosis mechanisms probably result from long coevolutionary histories of competition between pathogen and host. Conversely, in cancers, social heterosis is a by-product of recent mutations. Investigating how social genomes arise and function in viral quasi-species swarms and cancer tumours may lead to new therapeutic approaches. predictions, however, are far more specific, such as heterogeneous groups exhibiting replicative complementation or evolutionary convergence of certain allele combinations across different hosts. We, therefore, expand on the previous application to HIV by searching the literature for other potential examples that are consistent with one or more of the social heterosis predictions (table 1) . We consider two very different systems, viral infections, and cancer growth and spread. Each one has characteristics that seem favourable for creating for social heterosis: (i) the formation of localized groups of genetically variable virions or cell lineages; (ii) across-group variation in genetic diversity; and (iii) the potential that heterogeneity correlates with group-level virulence or tumour growth and metastasis. Finding multiple studies across different types of cancer and taxonomic groups of viruses that match predictions would suggest that social heterosis is indeed a relevant concept for evolutionary medicine to consider, especially in regard to future therapeutic practices. We initially screened the extant literature (to early 2020 in Web of Science, JStor and Google Scholar) on cancers and viruses for evidence of social heterosis by using the keywords 'genetic diversity', 'cooperation', 'synergistic interactions', 'mutualistic interactions', 'group diversity', 'quasispecies' and 'group selection'. After identifying relevant studies, we expanded our search to examine papers that cited these original papers. If the original papers reviewed the literature, we examined papers therein that seemed appropriate, but had not been identified in our initial search. The literature review is biased in that we primarily searched for evidence suggestive of social heterosis, rather than a comprehensive review of all the ways that cancers and viruses could potentially proliferate. Figure 1 . Social heterosis in cancer tumours and metastasis. Genetically diverse 'neighbourhoods' within a tumour can replicate more rapidly due to mutated cell lineages having a greater tool kit in terms of extracting resources from the host or defending against immune system responses. Although each lineage may only have a specific genetic advantage, the benefits produced by those enhanced capabilities are shared by all cells in close proximity. Thus, as the tumour grows, genetic diversity is maintained and entire neighbourhoods can function as complementary social genomes. Metastatic ability and success can also be enhanced in polyclonal circulating tumour cells (CTCs) relative to monoclonal CTCs. royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 3 The individual studies found in the literature search (tables 2 and 3) are listed with how consistent they are or are not with predictions from the social heterosis hypothesis (table 1). Across virus studies, RNA viruses provide considerably more evidence for social heterosis than do DNA viruses (table 2) . RNA viruses produce a low-fidelity polymerase, resulting in high mutation rates [110, 111] . Over the course of an infection in a host, a single infecting clone can rise to large number of new clones that vary in one or more mutations from the original genotype (i.e. forming a quasispecies population). The genetically related variants often centre around a consensus sequence with their relative frequencies fluctuating over time [25, 110] . Diversity may be inherited between hosts via co-packaging of genomes into single viral units or by a single infecting strain that rapidly reestablishes diverse populations after a transmission bottleneck [110, 112] . For many RNA viral infections, higher diversity is correlated with increased virulence and larger viral load [111] . Variants may differ in biological characteristics which affect adaptive potential, such as capacity to escape the host immune system and resist antiviral or antibody treatments [24, 111] . Interactions among genetically diverse variants can potentially contribute to replication rate, thermal stability, interferon release, entry and exit in cells, fighting neutralizing antibodies, antiviral resistance or other aspects of viral fitness [110] . Synergistic interactions at the population level can also influence burst size, viral load and chronicity of infection [24] . The presence of certain variants in a population, even low-frequency ones, can play a large role in infection severity [27] . Certain RNA viruses provide stronger evidence for social heterosis compared with others (table 2) . For example, hepatitis B, influenza, measles, MERS and chikungunya viruses present strong evidence in support of social heterosis. Hepatitis B exhibits rapid diversification at specific loci during early infection, which slows down as the disease progresses potentially due to the elimination of non-complementary genomes [4, 5] . If heterogeneous co-infections are overall more productive than homogeneous ones, group-level selection can overcome within-cell individual-level selection for replicative success. Note that in some viruses, co-infection can also result from more than one genome being packaged in protein capsids. royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 [19] . In Influenza infections, groups with greater genetic diversity at particular loci were more productive compared with homogeneous groups, suggesting the presence of synergistic interactions between such loci [28] . Measles viruses carry multiple genomes which code for different functional proteins that synergistically interact to increase viral spread in culture [44] . Successful measles infections rely on en bloc transmission to a new host, where multiple genomes were transmitted at once due to diversity being a necessity for rapid dispersal [44] . Individuals infected with the highest level of diversity of MERS viruses became 'super spreaders'. There is a strong correlation between the co-occurrence of certain variants, supporting selection beyond the individual level [50] . Aggregates also formed to co-infect cells and create chimeric plaques [36] . In Chikungunya infections, genomic diversity correlated with higher viral productivity and disease severity in line with social genome theory [52] . In cancer, the evidence for social heterosis is strongly suggestive (table 3) . Most tumours are heterogeneous ecosystems of interactive cell populations [74, 113] . In many cancers, increased tumour diversity correlates with faster growth rate, higher malignancy and higher resistance to therapy (table 3) . Polyclonal seeding occurs when CTC clusters collectively invade instead of single cells and are associated with improved survival in the bloodstream, higher colonization success in distant Overall patterns of genetic diversity consistent with social heterosis (1) Naturally occurring populations of pathogens are always diverse; genetic similarity or relatedness of pathogens negatively correlates with group-level success. [10] . (2) Diversity is always lowest when pathogens first infect hosts or at early stages of primary tumour growth and then significantly increases over time. (3) Diverse pathogen or cancer cell populations are more often associated with increased replication and negative health outcomes than monoclonal populations. (4) Transmission bottlenecks can disrupt social genomes, requiring in situ evolution through random mutations and stochastic co-occurrence of complementary genotypes. This could produce significant variance in pathogen virulence or metastatic tumour growth across hosts. Interactions across genotypes or phenotypes consistent with social heterosis. (1) For pathogens, immediate virulence negatively correlates with the severity of a genetic bottleneck at transmission. For cancers, the likelihood of metastasis positively correlates with genetic heterogeneity of circulating tumour cells (CTCs). (2) Complementary interactions occur between genetically different pathogens or cancer cells. Particularly compelling is where clones genetically differ at the same loci. (3) No single clone strain, wild-type or consensus sequence will have equal or higher replicative success than at least one combination of genetically diverse clones. (4) Genotypes at pathogen infection or early primary tumours may be rare or absent when infections become chronic or cancers become metastatic. (5) Not all genotypes will have equal replicative success within a local group or cell aggregation. Genotype fitness may vary across tissues or in terms of effectively exploiting host resources or evading host immunological defences. (6) Frequency-dependent selection across genotypes will be weak or non-existent. Absolute co-occurrence of complementary genotypes has a greater effect than relative frequencies. Genetic diversity is a precondition for social heterosis. Effects may be more rescue and mutualism than social heterosis. (O2) RNA: Picornaviridae; Enteroviruses polio Viral mutation rates have evolved to be higher as a result of selection for viruses with faster replication kinetics. Suggests more rapid production of mutants, rather than genetic diversity, is the important factor. [37] Shows the mutation rates that produce high genetic diversity may be an evolved, adaptive trait. ( breast Circulating tumour cell (CTC) clusters have 23-to 50-fold increased metastatic potential and abundance of CTC clusters denote adverse outcomes. Heterogeneity within CTC clusters is closely related to cellular-scale genetic heterogeneity within tumours. [54] Heterogeneous groups of cancer cells produce more aggressive tumours. (O3) breast Heterotypic interactions between epithelial subpopulations are critical to collective invasion of breast tissue. [55] Genetically diverse cancer populations are more invasive. (O3) breast Polyclonal seeding by cell clusters in a mouse model of breast cancer accounts for >90% of metastases. Tumour cell clusters induced greater than 15-fold increase in colony formation ex vivo and greater than 100-fold increase in metastasis formation in vivo. [56] Heterogeneous groups of CTCs are more successful at metastasis. (I1) breast Two subclones are required for efficient tumour propagation in mice. When biclonal tumours are challenged by withdrawing a clone, they recruit heterologous cells to restore tumour growth. [57] Genetically different clones form complementary pairings. These subclones are the most common, suggesting their presence requires group-level selection. (I2) breast Plakoglobin, as a key component in cell adhesion, can promote collective metastasis. Tumour emboli were associated with a high frequency of metastasis. [58] Heterogeneous groups are more successful at metastasis. (I1) breast Minor subclones in breast cancer cooperate to promote metastatic spread and generate polyclonal metastases composed of driver and neutral subclones. [59] Genetically different clones form synergistic pairings. breast The co-injection and co-growth of two different breast cancer cell line subclones resulted in increased efficiency of migration and invasion. A subclone on its own was unable to form lung metastases. [63] Genetically different clones form and require complementary pairings to succeed. (I2) breast Tumour growth in a mouse xenograft can be driven by a minor cell subpopulation, which enhances the proliferation of all cells within a tumour by overcoming environmental constraints, but can be outcompeted by faster proliferating competitors, resulting in tumour collapse. [64] Genetically different clones form complementary pairings. These subclones are the most common, suggesting their presence requires group-level selection. (I2,I6) breast Tumours with high heterogeneity correlated with worse survival. High diversity tumours had less activation of immune response and decreased infiltration of anti-tumour cytotoxic and helper T-cells. [65] Heterogeneous CTCs produce more aggressive tumours. Diverse tumours better defend against immune systems. (I1) breast Mammary non-metastatic carcinoma cell lines metastasized to the lungs only when co-injected into mice with highly metastatic clones. [66] Genetically different clones form and require complementary pairings to succeed. (I2) breast CTC clusters are more pronounced in patients with inflammatory breast cancer, the most aggressive form of breast cancer with the poorest survival. [67] Heterogeneous CTCs produce more aggressive tumours. (I1) breast Found a high degree of genetic heterogeneity both within and between distinct tumour cell populations. Some tumours were markedly different between the in situ and invasive cell populations. [68] The leukaemia Murine leukaemia with four antigenically different subtypes of leukaemia cells had severe negative impacts on therapeutical effect of monoclonal antibodies. Intratumoural heterogeneity with respect to these antigens was also found in humans. [83] Genetic diversity observed in mouse and human cancers and correlates to negative outcomes. (O3) leukaemia 10 of 12 chronic lymphocytic leukaemia cases treated with chemotherapy (versus 1 of 6 without treatment) underwent clonal evolution, predominantly involving subclones with multiple driver mutations that expanded over time. The presence of subclones predicts adverse clinical outcomes. [84] Group-level selection for the most effective social genome against chemotherapy. (O5,17) leukaemia Clonal progression is the key feature of transformation to invasiveness. The clinically predominant invasive clone first arises in the non-invasive stage. [85] It takes some time for complementary mutations to arise to create invasiveness. (O4) leukaemia: lymphocytic Patients carried multiple STAT3 mutations, which were located in different lymphocyte clones. The size of the mutated clone correlated well with the degree of clonal diversity. [86] Genetic diversity observed in cancer progress and correlated with increased cancer cell presence. (O3) leukaemia Negative outcomes correlate with cellular genetic diversity. Mutations affecting specific kinase signalling pathways were enriched in progressive relative to non-progressive patients. [87] Genetic diversity correlates with negative outcomes. The same mutations and combinations observed repeatedly. (O3, I5 and 7) lung, colon and breast CTCs composed of multiple clones of cancer cells or composed of cancer and non-cancer cells are more likely to result in poor outcomes. [88] Genetically diverse cancer populations are more invasive. (O3) lung Cellular and morphological heterogeneity correlates to prognostic failure of drugs approved for nonsmall cell lung cancer. [89] Genetically diverse cancer populations are more invasive. (O3) lung and brain Metastatic cells can bring stromal components including activated fibroblasts from the primary site to the lungs. Brain metastases from lung and other carcinomas contain carcinoma-associated fibroblasts, in contrast with primary brain tumours. [90] Different social genomes can arise in different tissues and successfully metastasize. (I5) lung Intratumour heterogeneity mediated through chromosome instability is associated with increased risks of recurrence or death. [91] Genetically diverse cancer populations are more invasive. (O3) lung Polyclonal seeding of metastases occurs in a murine model of small cell lung carcinoma. [92] Genetically diverse cancer populations are more invasive. (O3) (Continued.) royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 Populations are genetically diverse and clones vary in their growth potential. (O1,I5) pancreatic The level of circulating tumour microemboli is an independent negative predictor of poorer overall survival and progression-free survival. [101] Heterogeneous CTCs produce more aggressive tumours. (I1) pancreatic In a mouse model, precursor lesions exhibit high heterogeneity but diversity decreases during premalignant progression. A significant fraction of metastases, however, are polyclonally seeded by distinct subclones. This suggests heterotypic interactions between tumour subpopulations contribute to metastatic progression. [102] Genetic diversity is important but in certain combinations. pancreatic Clonal populations in metastases are represented within the primary carcinoma, but are genetically evolved from the original parental, non-metastatic clone. It may take a decade between the initiating mutation and appearance of the parental, non-metastatic founder cell, 5 more years for acquisition of metastatic ability, and an average of 2 years to death. [103] Social heterosis may take a long and variable time because complementary mutations must both arise and be spatially close. (I4) prostate Metastases can spread via polyclonal seeding, as observed in patients with prostate tumours. [104] Genetically different clones form complementary pairings. (I2) prostate The invasiveness of the cancer stem cell-enriched subpopulation is enhanced by the non-cancer stem cell population, accelerating metastatic spread. [105] Heterogeneous groups of cancer and non-cancer cells are more successful at metastasis. (O3) multiple cancer types Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number gains. Timing analyses suggest driver mutations often precede diagnosis by many years, if not decades. [106] Some mutations are essential. Social heterosis may take a long and variable time because complementary mutations must both arise and be spatially close. (O4,I7) multiple cancer types CTCs can migrate from secondary metastatic tumours back to the primary tumour, increasing its diversity and growth rate (self-seeding). [107] Heterogeneous groups are more successful at metastasis. (I1) multiple cancer types Oncogenic mutations frequently are present as subpopulations within tumours, rather than as the pure mutant populations expected to develop from a single initiated cell. [108] It takes some time for complementary mutations to arise to create invasiveness. (O4) multiple cancer types Within seven types of untreated epithelial cancers, primary tumours are genetically homogeneous with respect to functional driver-gene mutations in metastases. [109] Diversity evolves in different pattern across genomes, where some mutations are essential for the social genome. (I7) royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 tissues and promotion of stem-like behaviour [75, 88, 114, 115] . Clusters may have up to a 50-fold higher rate of metastasis compared with single cells [63, 116] . While cell-intrinsic properties and specific driver mutations lead to the epithelial to mesenchymal transitions that precede metastasis, cells with these mutations alone may not survive migrating in the circulatory system to establish new lesions at distant organs [106, 115, 117] . Thus, even with strong selective pressures for driver mutations, tumour diversity is maintained throughout cancer progression [64, 115] . Indeed, interactions between tumour subclones contribute to faster and more efficient metastases in many cancers [74, 88, 114, 118] . Several cancers show strong evidence for social genomes and patterns of diversity which correlate with increased aggression of tumours (table 3) . Breast cancers exhibit CTC clusters composed of genetically distinct subclones which are associated with worse survival for patients compared with those who lack CTC clusters [54, 56, 59, 61] . Similarly, colorectal, pancreatic and lung cancers also exhibit the presence of diverse CTC clusters which are correlated with poorer prognosis [76, 93, 101, 102] . The association between increased diversity and tumour aggression is also seen in oesophageal cancers [77, 78] . A pattern from ecological theory commonly found in natural communities is the competitive exclusion principle [119] [120] [121] [122] [123] [124] [125] [126] . Briefly stated, two species cannot coexist over time in the same ecological niche, when they are competing for the same set of essential resources. The better competitor in the majority of cases will drive the poorer competitor to extinction. Thus, within rapidly mutating quasi-species swarms of RNA viruses or cancer cell clone lineages, some genotypes should have an advantage at exploiting their surroundings and replicating. Over time, natural selection would be expected to favour the better adapted clones, and for such 'superclones' to proportionally dominate their respective populations and reduce the overall genetic diversity of the population. Inconsistent with the rise of one or a few dominant clones, however, the growth and metastasis of tumours and the virulence of viral infections often correlates with increasing genetic diversity, per se. The initial evolution and maintenance of clonal diversity could result from rescue effects. Genetically defective clones, unable to synthesize a vital product, can parasitize the output of viable ones in their vicinity (e.g. [31] ). In turn, such defective clones may provide a reciprocal benefit to functional or wild-type clones by indirectly helping in escaping attack by immune systems. Overall burgeoning diversity of both functional and defective creates 'too-many-targets' for the host's immune system, and the defences become overwhelmed. Should this happen, rescue effects and ineffective immune system control might weaken selection in favour of any particular genotype of pathogen or cancer cell line. This would create correlations between increasing genetic diversity and negative health outcomes. Our goal is not to evaluate how often superclone or too-many-targets models explain disease progression. Instead, we propose a third model that incorporates the genetically diversifying mechanisms evident in RNA virus and cancer cell replication, with the possibility that certain genetic combinations interact synergistically in complementary ways with each other. This requires social heterosis-the process in which groups of diverse and complementary genotypes can be more productive than groups composed of any single genotype [4] [5] [6] . Such fortuitous combinations will create a more complex genetic entity: the social genome. It is the within-host appearance and evolution of social genomes that can increase virulence in an infection, transition an acute condition to a chronic one and contribute to the metastatic tendencies of cancers. The social heterosis model makes a number of predictions about overall patterns of genetic diversity and genotypic or phenotypic interactions within a host (table 1). A review of the literature finds multiple studies with observations that match specific predictions across a variety of virus families (table 2) and multiple types of cancers (table 3) . Some of the supporting observations are general and could occur in the absence of social heterosis, such as pathogen populations being composed of multiple genotypes, quasi-species swarms of RNA viruses appearing because of low fidelity in replication, or cancer tumours becoming genetically heterogeneous because of genomic instability. The social heterosis model, however, also makes more specific predictions that would differ from patterns generated by either superclone or too-many-targets models. Thus, in a number of studies, only the social heterosis model is consistent with observations of genetic diversity initially increasing within a host, but then plateauing or declining with chronic or severely negative health outcomes; genetically diverse CTCs driving cancer metastasis; clear evidence of complementary interaction between genetically distinct clones ( particularly for genetic variants at the same loci); weak or absent frequency-dependent selection as genetic diversity increases in populations; and convergent evolutionary outcomes across hosts for particular mutations or allelic combinations. royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 If social heterosis occurs and is an important component for viral diseases and cancers, it fundamentally alters our perceptions of the conflict between disease and host. For example, the HIV genome is composed of only nine genes, yet it effectively manipulates hundreds of different human proteins [127] . Consider, however, that during the asymptomatic phase of an HIV infection, the virus is creating a polyploid entity that will compose the complementary social genome. The immune system being thereafter overwhelmed and collapsing when facing a cloud of synergistic, interactive genomes becomes less puzzling. Similarly, a typical cancer cell with a degraded or damaged genome would seem to stand little chance of survival by itself against a vigilant immune system [128] . However, groups of cancer cells, each with a different 'tool' to fend off immune responses and to manipulate non-cancerous cells in the immediate vicinity, become a formidable foe capable of growing and propagating throughout a body. Furthermore, to the degree that social heterosis is involved, then negative health outcomes are being evolutionarily driven by group-level selection processes. This may require a different way of thinking in terms of therapeutic approaches [4, 41, 46, 116, [129] [130] [131] . The fact that social heterosis can occur and social genomes may arise analogously in both quasispecies swarms of RNA viruses and cancer tumours leads to interesting evolutionary comparisons. Viruses and their hosts have been in a several billion-year coevolutionary arms race from perhaps the origin of life on Earth [132] . This arms race, however, is evolutionarily balanced. Mutations in a viral population that increase infectivity and the ability to use host resources are under positive selection. At the same time, any host mutation that helps stave off viral infection or ameliorates one should also be selectively favoured. By contrast, however, every new cancer literally replicates the origin of the first virus. There is no billion-year continuous history of interaction. Therefore, all evolutionary arms races begin in an unbalanced state. The host has billions of years of ancestors that either never got cancer or at least survived theirs long enough to reproduce. Whatever genetic constitution allowed the ancestor to win was passed to its descendants. Any favourable mutations that produce genetically successful cancers, however, die with the host. Neither winning nor losing cancers leave any offspring. With such a long evolutionary asymmetry in favour of beating cancer, it is somewhat paradoxical that cancer both exists and often wins the competition against their hosts' non-cancerous cells. The evolutionary advantages for social heterosis may also help explain a dichotomous distribution in viral genomics. For example, viruses that attack single-celled organisms have little opportunity to develop and evolve quasi-species swarms within the attacked cell. Therefore, suggestive of the importance of being able to make genetically diverse populations, across 47 recognized families of RNA viruses, only a few species in the families Leviviridae and Cystoviridae are known to be bacteriophages [133] . Instead, most RNA viruses attack multicellular eukaryotic species. Within eukaryotes, RNA virus reproduction is predominantly lytic (replicating rapidly within cells and killing them) rather than lysogenic (incorporating into a host's DNA and replicating with the host). Only retroviruses (four families in the order Ortervirales) make DNA copies of their RNA that can be inserted in host genomes. HIV is the best studied retrovirus and although it may have lysogenic capabilities, its lytic life history produces quasi-species swarms that correlate to immune system collapse [6] . Increasing the number of reproductive generations along with a high mutation rate allows quasi-species swarms to appear in the longer-lived multicellular hosts [41, 134] . The fact that RNA replication is highly error prone and rapidly produces genetic diversity may be actually a vital adaptation whose rate is optimally tuned. It is possible to manipulate viruses into replicating with less error, but such manipulations make the viruses less successful rather than more so [37, 38, 40, 135] . In terms of treatment regimes for specific viral diseases, it may, therefore, be an important consideration as to whether the virus has an RNA or DNA genome. For example, if replication error rates are too high, populations of viruses could produce so many defective genotypes that the population no longer has enough viable individuals to sustain itself. The population crosses a threshold into a state of 'error catastrophe' [136] . The very high mutation rates of RNA viruses suggest they are pushing close to where error catastrophe results in population extinction. Although this suggests that further increasing the mutation rate of a targeted RNA viral disease might have therapeutic value, such a strategy could also be counter-productive [137, 138] . For example, when RNA viruses are rapidly serially transmitted in vitro in the presence of mutagens, error catastrophe can occur and result in population collapse [139, 140] . Unfortunately, these methods probably fail to transmit any existing social genome through genetic bottlenecks and force a reset of social heterosis to its initial stage. In comparison, the results of increasing the mutation rate of a chronic, existing infection have little positive effect and even can potentially increase negative outcomes [141, 142] . Given that viruses have had a long evolution history towards solving the error catastrophe problem, it may be instead more effective to push their populations in the opposite direction. Hence, increasing replicative fidelity and decreasing recombination rates might be an effective strategy against RNA diseases. The reduced error rates and genetic exchange could increase the time, or prevent entirely, the evolution of a stable social genome. Indeed, an RNA virus that is unable to mutate or recombine at the onset of an infection might be quickly eliminated by host immune responses. In a simulated HIV infection, Nonacs & Kapheim [6] found that reintroducing a wild-type genotype that was competitively superior at the individual level of selection, disrupted any social genome that had formed and reduced viral loads. This suggests that a quasi-species swarm could be susceptible to being competitively constrained or eliminated by introducing a competing clone with high fidelity in replicating its genome, but without across-clone complementation. The fact that many cancers increase in frequency with organism age and across species strongly suggests that organism-level susceptibility to cancer is also an evolvable entity [143] . From the point of view of a tumour, however, it appears as a de novo organism in every patient, with the cancer's success or failure being entirely specific to only that patient. Thus, studying how the overall human immune system changes over time and compares with other more cancer-free species might be useful and informative in an evolutionary medicine context. For example, the taxonomic distribution of cancer across species strongly suggests it is far more prevalent in groups that strictly separate cell lineages into either the germ line (the gonads) or non-gamete-producing somatic tissue and organs [143] . Taxonomic groups (e.g. cnidarians) in which all or most cells retain their totipotency to switch to gamete production are far less likely to develop cancer. This cancer deficit occurs even though oncogenes (or at least their evolutionary precursors) are present in these groups [144] . Cancer cells themselves are proposed to be the equivalent of evolutionarily non-cooperative cheaters-as cells that in a sense rebel against imposed sterility and low growth [145, 146] . Cheaters, therefore, are paradoxically more common in taxa that in the course of normal ontogeny more strongly restrict and limit the range of cell lineage developmental trajectories. Furthermore, within individuals, more aggressive tumours with higher variability tend to arise in organs with apparently stronger anti-cancer defences in comparison with other tissues [147] . Such patterns are counterintuitive. Stronger controls that limit what function a cell can express ought to make cancers less likely rather than more so. Resolving why this apparent evolutionary paradox exists could lead to future therapeutic options. Complementation promoting tumour growth and creation of the tumour microenvironment can arise from cell-cell signalling, i.e. with the secretion of growth factors, hormones, cytokines, extracellular matrix regulators, tumourigenic fibroblasts and other factors affecting angiogenesis, oxygen metabolism and defence against the immune system [115, [148] [149] [150] . Due to the complexity of the tumour microenvironment, it is unlikely for single genotypes to be able to create the plasticity required to create and maintain a completely hospitable environment [59, 115, 130, 151] . Via complementation among heterogenous genotypes, however, it is possible to create a system of labour division where all group members can benefit in accordance with functional social genomes. The lack of any coevolutionary history between cancerous and non-cancerous cells, however, forces the conclusion that complementation and social genomes in cancer tumours and metastases are serendipitous by-products of unstable and mutable genomes. Targeting single clones for therapy often fails to predict the properties of a mixed population [152] . Therefore, incorporating the ideas of social heterosis could be valuable in improving the treatment of cancer, but this requires thinking in general terms about the process. One such aspect is that a social genome can be a network of interdependent genes. Some mutations or clonal variants may perform redundant functions. Thus, attacking or eliminating a particular clone, even if the mutation it carries is associated with increased malignancy, may have no effect on disease progression. Instead, there may be a 'keystone' genetic change within a social heterosis network-which if eliminated-severely impacts a tumour's ability to grow and metastasize. Social heterosis predicts that a clonal line carrying such a keystone needs to be common enough to be a regular member of a CTC or tumour, but it need not be the most common cell type or exhibit any significantly measurable frequency-dependent effects. Unfortunately, such keystone changes may very well differ across patients and, therefore, not lead to a general treatment. However, some types of cancers may indeed have a particular pathway or keystone change that needs to convergently evolve across patients that otherwise produce genetically unique tumours at a population level of cancer cells. To the degree that any such changes are seen to be shared across patients, the clonal lineages with those changes might be particularly useful for therapies to directly target. Genetic diversity with social heterosis means targeting population heterogeneity could disrupt synergistic interactions and lessen disease progress. Quasi-species expansion in RNA viral infections could be prevented by increasing RNA polymerase fidelity, or conversely, at the earliest stages of royalsocietypublishing.org/journal/rsos R. Soc. Open Sci. 8: 202219 infection pushed past their error threshold by decreasing fidelity [153] [154] [155] . Similarly, cancer drugs that induce mitotic catastrophe, disruptively intercalate DNA or affect genes such as TP53 that help regulate chromosomal stability could directly target tumour heterogeneity and hinder the synergistic interactions of social heterosis [156] . Data accessibility. This article has no additional data. Authors' contributions. S.E. and P.N. jointly conceived the idea and jointly wrote and edited the paper. S.E. did most of the literature search. S.E. and P.N. both evaluated that literature relative to the hypothesis being tested. Both authors gave final approval for submission. The tragedy of the commons The tragedy of the commons in evolutionary biology Unrestricted migration favours virulent pathogens in experimental metapopulations: evolutionary genetics of a rapacious life history Social heterosis and the maintenance of genetic diversity Social heterosis and the maintenance of genetic diversity at the genome level Modeling disease evolution with multilevel selection: HIV as a quasispecies social genome Cultural evolution and emergent group-level traits through social heterosis Evolution of cooperation among tumor cells Structured demes and the evolution of group-advantageous traits Go high or go low? Adaptive evolution of high and low relatedness societies in social hymenoptera The proportion of revertant and mutant phage growing in a population, as a function of mutation and growth rate Host ecology determines the relative fitness of virus genotypes in mixed-genotype nucleopolyhedrovirus infections Genotypic and phenotypic diversity within the neonatal HSV-2 population Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host Impacts of genome-wide analyses on our understanding of human herpesvirus diversity and evolution Evolution and diversity in human herpes simplex virus genomes Increase in the genetic polymorphism of varicella-zoster virus after passaging in in vitro cell culture New insights into the evolutionary rate of hepatitis B virus at different biological scales Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes Intrahost selection pressures drive rapid dengue virus microevolution in acute human infections Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection The quasispecies nature and biological implications of the hepatitis C virus Endless forms: within-host variation in the structure of the West Nile virus RNA genome during serial passage in bird hosts Inter-versus intra-host sequence diversity of pH1N1 and associated clinical outcomes Whole genome sequencing of a (H3N2) influenza viruses reveals variants associated with severity during the 2016-2017 season Genetic diversity and host adaptation of avian H5N1 influenza viruses during human infection The evolution of a superswarm of foot-and-mouth disease virus in cattle Evolutionary transition toward defective RNAs that are infectious by complementation A selective bottleneck shapes the evolutionary mutant spectra of enterovirus A71 during viral dissemination in humans Is group selection a factor modulating the virulence of RNA viruses? Estimating viral bottleneck sizes for FMDV transmission within and between hosts and implications for the rate of viral evolution Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing Strength in numbers: mechanisms of viral co-infection A speed-fidelity trade-off determines the mutation rate and virulence of an RNA virus Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice Bottleneckmediated quasispecies restriction during spread of an RNA virus from inoculation site to brain Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence HIV populations are large and accumulate high genetic diversity in a nonlinear fashion Stronger together: multi-genome transmission of measles virus Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity In vivo evidence for quasispecies distributions in the bovine respiratory syncytial virus genome Rabies virus quasispecies: implications for pathogenesis Densitydependent selection in vesicular stomatitis virus Social evolution of innate immunity evasion in a virus Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb. Mol. Case Stud. 2, a001214 Ribavirin causes error catastrophe during hantaan virus replication Chikungunya virus fidelity variants exhibit differential attenuation and population diversity in cell culture and adult mice Evolvability of an RNA virus is determined by its mutational neighbourhood Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis Collective invasion in breast cancer requires a conserved basal epithelial program Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers High expression of plakoglobin promotes metastasis in invasive micropapillary carcinoma of the breast via tumor cluster formation Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models The role of clonal communication and heterogeneity in breast cancer Non-cellautonomous driving of tumour growth supports sub-clonal heterogeneity Tumor heterogeneity correlates with less immune response and worse survival in breast cancer patients Cellular interactions in metastasis Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Metapopulation dynamics and spatial heterogeneity in cancer Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients 2020 Quantification of multicellular colonization in tumor metastasis using exome-sequencing data Cell heterogeneity and phenotypic plasticity in metastasis formation: the case of colon cancer Circulating tumor microemboli (CTM) and vimentin + circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy Association between spatial heterogeneity within nonmetastatic gastroesophageal adenocarcinomas and survival Biological significance of tumor heterogeneity in esophageal squamous cell carcinoma Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistance From astrocytoma to glioblastoma: a clonal evolution study Epithelialmesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth Phenotypic diversity in leukemia cell populations Evolution and impact of subclonal mutations in chronic lymphocytic leukemia Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia Bring along your friends: homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer Malignant cells facilitate lung metastasis by bringing their own soil Tracking the evolution of non-small-cell lung cancer Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma Heterogeneous tumor subpopulations cooperate to drive invasion Molecular and genetic diversity in the metastatic process of melanoma Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells Molecular pathogenesis of multiple myeloma Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma Pancreatic cancer metastases harbor evidence of polyclonality Distant metastasis occurs late during the genetic evolution of pancreatic cancer The evolutionary history of lethal metastatic prostate cancer SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations The evolutionary history of 2,658 cancers Tumor self-seeding by circulating cancer cells Many different tumor types have polyclonal tumor origin: evidence and implications An analysis of genetic heterogeneity in untreated cancers Viral quasispecies Impact of RNA virus evolution on quasispecies formation and virulence Ecology and evolution of facilitation among symbionts Distinctive properties of metastasis-initiating cells Circulating tumor cell clusters: united we stand divided we fall 2020 Paracrine and cell autonomous signaling in pancreatic cancer progression and metastasis Metastasis and the evolution of dispersal Intratumoral heterogeneity: clonal cooperation in epithelial-to-mesenchymal transition and metastasis Tumorigenesis: it takes a village Influence of interspecific competition and other factors on distribution of barnacle Chthamalus stellatus Competition in tropical stream fishes-support for competitive exclusion principle A competitive-exclusion principle for pathogen virulence Basic concepts in RNA virus evolution Competitive exclusion after invasion? Competitive exclusion in a multi-strain immuno-epidemiological influenza model with environmental transmission Theory-based ecology: a Darwinian approach Competitive exclusion and evolution: convergence almost never produces ecologically equivalent species Identification of host proteins required for HIV infection through a functional genomic screen Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response Viral quasispecies profiles as the result of the interplay of competition and cooperation Cancer as an evolutionary and ecological process 2020 Intratumor heterogeneity: the Rosetta stone of therapy resistance Medusavirus ancestor in a proto-eukaryotic cell: updating the hypothesis for the viral origin of the nucleus Bacteriophage: genetics and molecular biology Viral quasispecies. Virology 479-480 Polymerase fidelity contributes to foot-andmouth disease virus pathogenicity and transmissibility in vivo Pathways to extinction: beyond the error threshold Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity Examining the theory of error catastrophe Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics Lethal mutagenesis of an RNA plant virus via lethal defection Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-I Vif and APOBEC3) Resistance of high fitness hepatitis C virus to lethal mutagenesis Cancer across the tree of life: cooperation and cheating in multicellularity Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer Nedelcu AM. 2020 The evolution of multicellularity and cancer: views and paradigms Differences in mutational processes and intratumour heterogeneity between organs Hallmarks of cancer: the next generation Clonal evolution in cancer Cancer drug resistance: an evolving paradigm 2020 A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells Intratumour heterogeneity: a looking glass for cancer? Ribavirin-resistant variants of foot-andmouth disease virus: the effect of restricted quasispecies diversity on viral virulence Attenuation of RNA viruses by redirecting their evolution in sequence space Viral RNA-dependent RNA polymerase mutants display an altered mutation spectrum resulting in attenuation in both mosquito and vertebrate hosts Targeting the CINful genome: strategies to overcome tumor heterogeneity Competing interests. We declare we have no competing interests. Funding. We received no funding for this study.